Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Ita...
Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis
About this item
Full title
Author / Creator
Publisher
Macclesfield: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
Macclesfield: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Objective: To assess the cost-effectiveness of obinutuzumab (O-chemo) in comparison to rituximab (R-chemo) in patients with untreated advanced follicular lymphoma (FL) at intermediate or high risk from an Italian National Health Service (NHS) perspective. Methods: A previously developed four-state Markov model was adapted to estimate lifetime clini...
Alternative Titles
Full title
Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_340a815a95484415b435f5ca72d30a55
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_340a815a95484415b435f5ca72d30a55
Other Identifiers
ISSN
1178-6981
E-ISSN
1178-6981
DOI
10.2147/CEOR.S317885
